111 related articles for article (PubMed ID: 3909792)
1. [Renal infections and implicated urinary stone formation].
Hirano S; Ohkawa M; Nakajima T; Orito M; Sugata T; Hisazumi H
Hinyokika Kiyo; 1985 Aug; 31(8):1387-91. PubMed ID: 3909792
[TBL] [Abstract][Full Text] [Related]
2. Urinary calculi and urinary tract infection. A clinical and microbiological study.
Holmgren K
Scand J Urol Nephrol Suppl; 1986; 98():1-71. PubMed ID: 3026032
[TBL] [Abstract][Full Text] [Related]
3. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
[TBL] [Abstract][Full Text] [Related]
4. [Recurrence of upper urinary tract calculi].
Mitsuhashi S; Hikage T; Kawamura K; Masukagami T; Matsuzaki A
Hinyokika Kiyo; 1988 Sep; 34(9):1549-55. PubMed ID: 3213791
[TBL] [Abstract][Full Text] [Related]
5. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
[TBL] [Abstract][Full Text] [Related]
6. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
Massey LK; Sutton RA
J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
[TBL] [Abstract][Full Text] [Related]
7. Routine analysis of urinary calculi by scanning electron microscopy.
Leusmann DB
Scan Electron Microsc; 1983; (Pt 1):387-96. PubMed ID: 6635559
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
[TBL] [Abstract][Full Text] [Related]
9. Retrograde ureteropyeloscopic treatment of 2 cm. or greater upper urinary tract and minor Staghorn calculi.
Grasso M; Conlin M; Bagley D
J Urol; 1998 Aug; 160(2):346-51. PubMed ID: 9679874
[TBL] [Abstract][Full Text] [Related]
10. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
11. Stone matrix as proteins adsorbed on crystal surfaces: a microscopic study.
Khan SR; Finlayson B; Hackett RL
Scan Electron Microsc; 1983; (Pt 1):379-85. PubMed ID: 6635558
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic evidence of calculus attachment to Randall's plaque.
Matlaga BR; Williams JC; Kim SC; Kuo RL; Evan AP; Bledsoe SB; Coe FL; Worcester EM; Munch LC; Lingeman JE
J Urol; 2006 May; 175(5):1720-4; discussion 1724. PubMed ID: 16600740
[TBL] [Abstract][Full Text] [Related]
13. Crystallization properties in urine from calcium oxalate stone formers.
Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
[TBL] [Abstract][Full Text] [Related]
14. Studies on structure of calcium oxalate monohydrate renal papillary calculi. Mechanism of formation.
Grases F; Costa-Bauzá A; Conte A
Scanning Microsc; 1993 Sep; 7(3):1067-73; discussion 1073-4. PubMed ID: 8146607
[TBL] [Abstract][Full Text] [Related]
15. [A bacteriological study on urinary calculi associated with infections].
Yoshida O; Kiriyama T; Okada K; Okada Y; Watanabe H; Mishina T; Uchida M; Watanabe K; Tomoyoshi T; Takayama H
Hinyokika Kiyo; 1984 Feb; 30(2):191-8. PubMed ID: 6741755
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque.
Evan AP; Coe FL; Lingeman JE; Shao Y; Sommer AJ; Bledsoe SB; Anderson JC; Worcester EM
Anat Rec (Hoboken); 2007 Oct; 290(10):1315-23. PubMed ID: 17724713
[TBL] [Abstract][Full Text] [Related]
17. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR
J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
[TBL] [Abstract][Full Text] [Related]
18. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
Favus MJ; Coe FL
Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
[TBL] [Abstract][Full Text] [Related]
20. The relation between urinary tract infections and stone composition in renal stone formers.
Holmgren K; Danielson BG; Fellström B; Ljunghall S; Niklasson F; Wikström B
Scand J Urol Nephrol; 1989; 23(2):131-6. PubMed ID: 2667113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
